• Home
  • About Us
  • Contact Us
  • Home
  • About Us
    • News & Press Releases
  • For Patients
    • EPIFLO: A New and Better Way to Treat Wounds
    • 10 Reasons to use EPIFLO® Now!
    • Benefits of EPIFLO Over Other Therapies
    • How does EPIFLO® compare with Negative Pressure Wound Therapy (ie. Wound VAC ®)?
    • How does EPIFLO® compare to Hyperbaric Oxygen Therapy?
    • Wound Care and Amputation
    • Indications for Use
  • For Clinicians
    • Indications for Use
    • Clinical Information
    • Case Studies
    • How does EPIFLO® compare with Negative Pressure Wound Therapy (ie. Wound VAC ®)?
    • How does EPIFLO® compare to Hyperbaric Oxygen Therapy?
    • Conferences and Trade Shows
    • EPIFLO Users Guide Video (English)
    • EPIFLO Users Guide Video (Spanish)
  • FAQ’s
  • Contact Us

Newsletter Signup

EPIFLO® Transdermal Continuous Oxygen Therapy [TCOT]

News & Press Releases

"Ogenix receives CE Mark allowing EPIFLO sales in Europe." Press Release, 2009 February 24.

“Ogenix to Showcase the EPIFLO® for Treatment of Diabetic Foot and Leg Ulcers at Workers’ Compensation Conference” Press Release, 2008 Aug 02.

“Ogenix to Participate in Third Congress of the World Union of Wound Healing Societies in Toronto” Press Release, 2008 May 22

"Transdermal sustained-delivery oxygen improves epithelial healing in a rabbit ear wound model.” Archives of Surgery, 2005 Oct

"Claire Wilson: Making Every Effort" – Cleveland Plain Dealer

"Wall Street Journal Recognizes Ogenix for Technology Innovation".

"FDA Clears EPIFLO® for Chronic Non-Healing Wounds"

"Oxygen device able to heal chronic wounds" – Cleveland Plain Dealer

  • Privacy Policy
  • Site Map
Copyright © 2012 ogenix.com. All Rights Reserved.